Relationship of comorbid personality disorders to prospective outcome in bipolar disorder.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 11 2020
Historique:
received: 02 12 2019
revised: 26 06 2020
accepted: 13 07 2020
pubmed: 23 7 2020
medline: 16 2 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

Introduction There is a high incidence of Axis II personality disorders (PDs) in patients with bipolar illness, but their influence on the prospectively measured course of bipolar disorder has been less well explicated. Methods 392 outpatients with bipolar disorder gave informed consent, completed the PDQ4 99 item personality disorder rating, and where clinically rated during at least one year of prospective naturalistic treatment. They were classified as Well on admission (N = 64) or Responders (N = 146) or Non-responders (N = 182) to treatment for at least six months. Results Patients who were positive for PDs were very infrequently represented in the category of Well on admission. In addition, patients with borderline, depressive, and schizoid PDs were significantly more likely to be Non-responders compared to Responders upon prospective naturalistic treatment in the network. Conclusions Patients with bipolar disorder and comorbid PDs were in general less likely to be Well from treatment in the community at network entry or to be a Responder to prospective treatment in the network. Therapeutic approaches to patients with PDs deserve specific study in an attempt to achieve a better long-term course of bipolar disorder.

Identifiants

pubmed: 32697693
pii: S0165-0327(20)32476-9
doi: 10.1016/j.jad.2020.07.031
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-151

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Robert M Post (RM)

Bipolar Collaborative Network, Bethesda, MD, United States. Electronic address: robert.postmd@gmail.com.

Gabriele S Leverich (GS)

Bipolar Collaborative Network, Bethesda, MD, United States.

Susan McElroy (S)

Linder Center of Hope, Mason, OH, and Biological Psychiatry Program, University of Cincinnati Medical College, Cincinnati, OH, United States.

Ralph Kupka (R)

Department of Psychiatry, VU University Medical Center, Amsterdam, the Netherlands.

Trisha Suppes (T)

11 Professor of Psychiatry and Behavioral Sciences, Stanford University School of Medicine and V.A. Palo Alto Health Care System Palo Alto, CA, United States.

Lori Altshuler (L)

UCLA Mood Disorders Research Program and VA Medical Center, Los Angeles, CA, United States.

Willem Nolen (W)

Universitair Medisch Centrum Groningen (UMCG), Groningen, the Netherlands.

Mark Frye (M)

Mayo Clinic, Rochester, MI, United States.

Paul Keck (P)

University of Cincinnati College of Medicine Cincinnati, Lindner Center of HOPE Mason, OH, United States.

Heinz Grunze (H)

Chefarzt, Allgemein Psychiatrie Ost am Klinikum am Weissenhof, Privat-Dozent der PMU Nürnberg, Germany.

Michael Rowe (M)

Biostatistician Bipolar Collaborative Network, Bethesda, MD, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH